Mercer Global Advisors’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$24.6M Buy
160,764
+4,606
+3% +$706K 0.04% 281
2025
Q4
$24.1M Buy
156,158
+19,787
+15% +$2.59M 0.04% 291
2025
Q3
$17.5M Buy
136,371
+1,465
+1% +$179K 0.03% 344
2025
Q2
$16.3M Sell
134,906
-7,101
-5% -$800K 0.04% 287
2025
Q1
$15.8M Sell
142,007
-3,752
-3% -$399K 0.04% 271
2024
Q4
$14.2M Sell
145,759
-2,411
-2% -$257K 0.03% 283
2024
Q3
$17M Sell
148,170
-4,885
-3% -$554K 0.04% 230
2024
Q2
$14.5M Buy
153,055
+5,285
+4% +$531K 0.04% 237
2024
Q1
$14.3M Buy
147,770
+36,704
+33% +$3.76M 0.04% 244
2023
Q4
$11.2M Buy
111,066
+2,851
+3% +$275K 0.03% 283
2023
Q3
$11M Buy
108,215
+6,046
+6% +$614K 0.04% 253
2023
Q2
$10.3M Buy
102,169
+10,151
+11% +$1.02M 0.04% 286
2023
Q1
$8.47M Sell
92,018
-4,258
-4% -$372K 0.04% 300
2022
Q4
$8.73M Sell
96,276
-527
-0.5% -$44.4K 0.04% 297
2022
Q3
$7.36M Buy
96,803
+2,239
+2% +$186K 0.04% 289
2022
Q2
$7.99M Buy
94,564
+14,190
+18% +$1.24M 0.05% 262
2022
Q1
$7.05M Buy
80,374
+24,334
+43% +$2.11M 0.04% 297
2021
Q4
$4.9M Buy
56,040
+3,634
+7% +$302K 0.03% 381
2021
Q3
$4.29M Buy
52,406
+11,183
+27% +$1.01M 0.03% 389
2021
Q2
$3.76M Sell
41,223
-4,370
-10% -$389K 0.03% 389
2021
Q1
$3.9M Sell
45,593
-6,504
-12% -$584K 0.04% 348
2020
Q4
$4.92M Buy
52,097
+185
+0.4% +$16.2K 0.06% 231
2020
Q3
$4.51M Sell
51,912
-31,722
-38% -$2.75M 0.07% 215
2020
Q2
$7.3M Buy
83,634
+1,713
+2% +$148K 0.13% 114
2020
Q1
$6.75M Buy
81,921
+14,901
+22% +$1.33M 0.15% 120
2019
Q4
$6.35M Buy
67,020
+1,272
+2% +$114K 0.13% 141
2019
Q3
$5.71M Buy
65,748
+4,245
+7% +$381K 0.13% 136
2019
Q2
$5.62M Buy
61,503
+6,331
+11% +$536K 0.15% 125
2019
Q1
$4.75M Buy
+55,172
New +$4.43M 0.17% 110

Other funds holding NVS